I am currently a Research Fellow under Professor David Osborn in the Department of Psychiatry at University College London. My work involves the examination of large datasets, including the Camden and Islington Clinical Record Interactive Search system, to explore outcomes in people who use NHS mental health services.
My doctoral research, conducted under the supervision of Professor Carol Brayne and Dr. Andres Roman-Urrestarazu in the Department of Public Health and Primary Care at the University of Cambridge, focused on elucidating the social and economic epidemiology of substance-related disorders by examining administrative and routinely collected datasets, including admissions data and nationally representative surveys. Before my PhD, I worked at Avalere Health, a DC-based health policy and strategy consultancy, where my work with life science clients focused on market access and product commercialisation.
My areas of broad academic interest include: psychiatric epidemiology, urban health policy, and health services research. In addition, I am interested in interdisciplinary approaches to tackling social problems which may benefit from a public health lens, including criminal justice reform and social care policy.
- PhD in Public Health and Primary Care, University of Cambridge (2015-19)
- MSPH in Health Policy, Johns Hopkins University (2013-15)
- Certificate in Health Finance and Management (2013-15)
- Certificate in Public Health Informatics (2013-15)
- PGDip in Commerce (General Management), Thompson Rivers University (2012-13)
- BSc in Biology (Cell Biology and Genetics option), University of British Columbia (2007-12)
- BA (Hons) in English, University of British Columbia (2007-12)
Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS one. 2019; 14(8):e0221153.
Yang JC, Roman-Urrestarazu A, McKee M, Brayne C. Demographic, socioeconomic, and health correlates of unmet need for mental health treatment in the United States, 2002-16. IJEH. 2019;18(1):122.
Neicun J, Steenhuizen M, van Kessel R, Yang JC, Negri A, Czabanowska K, Corazza O, Roman-Urrestarazu A. Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom, and Sweden. PloS one. 2019;14(6): e0218011.
Roman-Urrestarazu A, Yang JC, Robertson R, McCallum A, Gray C, McKee M, Middleton J. Brexit threatens the UK’s ability to tackle illicit drugs and organised crime: what needs to happen now?. Health Policy. 2019;123(6):521.
Prilutskaya M, Yang JC, Roman-Urrestarazu A. Synthetic Cannabinoids, Opioids, and Polydrug Use: Clinical Implications. In: (Eds) Corazza, O, Roman-Urrestarazu, A. Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS. Routledge; 2018.
Roman-Urrestarazu A, Yang JC, Ettelt S, Thalmann I, Seguel Ravest V, Brayne C. Private health insurance in Germany and Chile: two stories of co-existence, segmentation and conflict. IJEH. 2018;17(1):112.
Yang JC, Roman-Urrestarazu A, Brayne C. Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States. PloS one. 2018;13(6):e0199741.
Yang JC, Roman-Urrestarazu A. "Self-reported use of novel psychoactive substances in the United States from 2007-14: trends in prevalence and user characteristics from the national surveys on drug use and health." Fifth international conference on novel psychoactive substances. 2017.